Cannabis in the News, Financial Results
Cronos Group Reports 2019 Fourth Quarter and Full-Year Results Should you buy this marijuana stock? See Cannin’s Comprehensive Analysis of Cronos Group Here. 30 MARCH 2020 Completed Audit Committee Review and Restated Certain 2019 Unaudited Interim Financial...
Cannabis in the News, Finance, Financial Results
Cronos Group Inc. to Report 2019 Fourth Quarter and Full-Year Financial Results on March 30, 2020 TORONTO, March 30, 2020 (GLOBE NEWSWIRE) — Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”) will report its 2019 Fourth Quarter and...
Cannabis in the News, Finance, Financial Results, Investment Opportunities
GrowGeneration Reports Record Fiscal Year 2019 Revenues of $80 Million 2020 Revenue Guidance Set at $130-$135 Million Adjusted EBITDA Guidance for 2020 is $11.5 Million-$13.5 Million Q1 2020 Revenue Guidance $31.5-$32.5 Million DENVER, March 27, 2020 /PRNewswire/...
Cannabis in the News, Finance, Financial Results, Health, Medical, Science, Hemp
Can-Fite Reports 2019 Financial Results & Provides Clinical Development Update Piclidenoson has been submitted for the treatment of coronavirus under compassionate use program in Israel Top-line data from Phase II Namodenoson trial for NASH expected during April...
Cannabis in the News, CBD in the News, Finance, Financial Results, Hemp, Research, Science
Therapix Biosciences Ltd. Announces Shareholder Conference Call TEL AVIV, Israel, March 25, 2020 /PRNewswire/ — Therapix Biosciences Ltd. (Nasdaq: TRPX) (the “Company”), a specialty, clinical-stage pharmaceutical company focusing on the development...
Cannabis in the News, Finance, Financial Results, International Cannabis News, Investment Opportunities, Stock Talk
Hot Cannabis Stock Pick for 2020, Alcanna, Announces Sales, Gross Margin, & Year-Over-Year Increases Our analysts continue to review the fundamentals behind Alcanna and believe that the company is one of the best cannabis stock investing opportunities for 2020....
